We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$174M
AUM Growth
+$15.3M
Cap. Flow
+$869K
Cap. Flow %
0.5%
Top 10 Hldgs %
22.23%
Holding
180
New
23
Increased
31
Reduced
71
Closed
28

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$1.79M
2
J icon
Jacobs Solutions
J
+$1.54M
3
AMGN icon
Amgen
AMGN
+$1.42M
4
PB icon
Prosperity Bancshares
PB
+$1.37M
5
LNG icon
Cheniere Energy
LNG
+$1.33M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$1.42M
2
FANG icon
Diamondback Energy
FANG
+$1.32M
3
VLO icon
Valero Energy
VLO
+$1.14M
4
EOG icon
EOG Resources
EOG
+$1.04M
5
ARW icon
Arrow Electronics
ARW
+$945K

Sector Composition

Rank Sector Weight
1 Industrials 22.1%
2 Healthcare 18.51%
3 Consumer Staples 13.38%
4 Financials 13.17%
5 Technology 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
126
Weyerhaeuser
WY
$16.1B
$317K 0.18%
10,240
-2,800
-21% -$86.8K
SHW icon
127
Sherwin-Williams
SHW
$78.5B
$297K 0.17%
1,250
DCI icon
128
Donaldson
DCI
$10.1B
$290K 0.17%
4,925
-400
-8% -$22.9K
XYL icon
129
Xylem
XYL
$25.1B
$287K 0.16%
2,600
NSC icon
130
Norfolk Southern
NSC
$71.9B
$283K 0.16%
+1,150
New +$272K
INTC icon
131
Intel
INTC
$513B
$276K 0.16%
10,433
-1,550
-13% -$43K
GD icon
132
General Dynamics
GD
$97B
$274K 0.16%
1,104
-1,000
-48% -$244K
VRTX icon
133
Vertex Pharmaceuticals
VRTX
$130B
$274K 0.16%
+950
New +$290K
ALL icon
134
Allstate
ALL
$65B
$271K 0.16%
2,000
MPC icon
135
Marathon Petroleum
MPC
$115B
$267K 0.15%
2,293
-250
-10% -$28.5K
CMCSA icon
136
Comcast
CMCSA
$86.7B
$241K 0.14%
6,900
WAT icon
137
Waters Corp
WAT
$41B
$240K 0.14%
+700
New +$221K
MAS icon
138
Masco
MAS
$13.6B
$234K 0.13%
5,010
MET icon
139
MetLife
MET
$62.4B
$230K 0.13%
3,175
-7,875
-71% -$564K
FLIC
140
DELISTED
First of Long Island Corp
FLIC
$228K 0.13%
12,675
-1,950
-13% -$35.4K
NEE icon
141
NextEra Energy
NEE
$169B
$226K 0.13%
2,700
INTU icon
142
Intuit
INTU
$88B
$224K 0.13%
575
-25
-4% -$9.92K
BEN icon
143
Franklin Templeton
BEN
$16.9B
$221K 0.13%
8,375
-7,610
-48% -$189K
DRI icon
144
Darden Restaurants
DRI
$23.7B
$221K 0.13%
1,600
TSN icon
145
Tyson Foods
TSN
$18.5B
$221K 0.13%
3,550
ABB
146
DELISTED
ABB Ltd
ABB
$221K 0.13%
7,250
-16,100
-69% -$469K
DHI icon
147
D.R. Horton
DHI
$39.2B
$201K 0.12%
+2,258
New +$181K
F icon
148
Ford
F
$53.8B
$120K 0.07%
10,350
-1,000
-9% -$12.8K
XRN
149
Chiron Real Estate Inc
XRN
$478M
$120K 0.07%
2,528
-2,037
-45% -$92.1K
AAP icon
150
Advance Auto Parts
AAP
$2.62B
-1,550
Closed -$242K

Similar funds

New England Research & Management's Q4 2022 Portfolio in Review

As of Q4 2022, New England Research & Management held 180 positions worth $174M, up 9.6% from $159M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q4 2022 filing shows 23 new, 31 increased, 71 reduced and 28 closed positions. Its largest new stake was Amgen: 5,280 shares worth $1.39M. The largest sale was Deere & Co, an estimated $1.42M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q4 2022 buy was Amgen: 5,280 shares worth $1.39M.
  • New England Research & Management added most to EQT Corp in Q4 2022, an estimated $1.79M increase.
  • New England Research & Management's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $1.42M.
  • New England Research & Management fully exited Diamondback Energy in Q4 2022, selling an estimated $1.32M.
  • New England Research & Management's ten largest holdings make up 22% of its $174M portfolio in Q4 2022.
  • New England Research & Management opened 23 new positions and closed 28 in Q4 2022.
  • New England Research & Management's portfolio value rose 9.6% quarter-over-quarter to $174M.

Based on New England Research & Management's 13F filing for Q4 2022, filed 9 Jan 2023.